United States · FDA National Drug Code directory
ANASCORP
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66621-0150_d0c33dec-842e-4cc0-9d8f-515d6efd8a0c
- Product NDC
- 66621-0150
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- centruroides (scorpion) immune F(ab)2 (equine)
- Labeler
- Rare Disease Therapeutics, Inc
- Marketing category
- BLA
- Marketing start / end (source format)
- 20110803
- Source listing expiry
- 20261231
Source-listed ingredients
- CENTRUROIDES FAB2 ANTIVENIN (EQUINE) — 7 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (66621-0150-2) / 10 mL in 1 VIAL (66621-0150-1) · 66621-0150-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →